Table 4.
Changes in dACC functional connectivity for the contrast incongruent greater than congruent following smoking cessation therapy with varenicline.
| Region | Hem | x, y, z | Cluster size | peak t-Value |
|---|---|---|---|---|
| BASELINE>WEEK 12 | ||||
| Inferior parietal | R | 36, −47, 45 | 655 | 7.69 |
| SupraMarginal gyrus | R | 279 | ||
| Superior occipital | R | 33, −72, 42 | 300 | 6.37 |
| Angular gyrus | R | 252 | ||
| Superior parietal | R | 237 | ||
| Inferior parietal | L | −18, −72, 45 | 549 | 5.41 |
| Superior parietal | L | 403 | ||
| WEEK 12 > BASELINE | ||||
| Superior medial frontal | R | 17, 48, 5 | 389 | 7.88 |
| Anterior cingulum | R, L | 202, 134 | ||
| Superior frontal | R | 190 | ||
| Superior medial frontal | L | 124 | ||
| Superior orbitofrontal | R | 110 | ||
| Posterior cingulum | L | −8, −24, 29 | 245 | 5.73 |
| Middle cingulum | L | 245 | ||
| Precuneus | R, L | 175, 170 | ||
| Posterior cingulum | R | 117 | ||
Hem, hemisphere; x, y, z refer to Montreal Neurological Institute coordinates. All regions are significant at a cluster level threshold of p < 0.05 FWE cluster level corrected.